Trial Profile
A Double-Blind, Placebo-Controlled, Randomized, Single and Multiple Ascending Dose Study (Including Food Effect, pH Effect, and Japanese Bridging Study) of the Safety, Pharmacokinetics, and Exploratory Pharmacodynamics of Oral BMS-986278 Administration in Healthy Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jul 2020
Price :
$35
*
At a glance
- Drugs BMS-986278 (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 20 May 2020 Results presented at the 116th International Conference of the American Thoracic Society
- 27 Sep 2019 Status changed from active, no longer recruiting to completed.
- 17 Dec 2018 Planned End Date changed from 3 Dec 2018 to 5 Mar 2019.